4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-052465
EVP, R&D & Chief Scientific Of sold 13,500 shares at $43.08 ($581,580)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Haqq Christopher EVP, R&D & Chief Scientific Of | 2018-09-26 | Sale | −13,500 | $43.08 | $581,580 | 286,355 | D |
| Open-market sales · 13,500 sh · avg $43.08 · $581,580 | |||||||
Loading xslF345X03/doc4.xml…